System and method for pre-processing waveforms

Information

  • Patent Grant
  • 7725146
  • Patent Number
    7,725,146
  • Date Filed
    Thursday, September 29, 2005
    18 years ago
  • Date Issued
    Tuesday, May 25, 2010
    14 years ago
  • CPC
  • US Classifications
    Field of Search
    • US
    • 600 301000
    • 600 310000
    • 600 322-324
    • 600 336000
    • 600 356000
    • 600 529000
  • International Classifications
    • A61B5/1455
    • A61B5/02
    • Term Extension
      1273
Abstract
A technique is provided for processing a physiological signal. The technique includes performing one or more multi-resolution decompositions on a physiological signal and one or more morphological operations on some or all of the respective decomposition components. In one embodiment, the technique is implemented as iteratively wavelet transformations where morphological operations, such as erosions and dilations, are applied to modify some or all of the respective wavelet coefficients. The modified wavelet coefficients may then be reconstructed to generate a clean version of the physiological signal from which some or all of the noise and/or artifacts have been removed.
Description
BACKGROUND OF THE INVENTION

1. Field of the Invention


The present invention relates generally to the processing of waveform data and, more particularly, to the processing of waveforms associated with medical monitoring.


2. Description of the Related Art


This section is intended to introduce the reader to various aspects of art that may be related to various aspects of the present invention, which are described and/or claimed below. This discussion is believed to be helpful in providing the reader with background information to facilitate a better understanding of the various aspects of the present invention. Accordingly, it should be understood that these statements are to be read in this light, and not as admissions of prior art.


In the field of medicine, doctors often desire to monitor certain physiological characteristics of their patients. Accordingly, a wide variety of devices have been developed for monitoring physiological characteristics. Such devices provide doctors and other healthcare personnel with the information they need to provide the best possible healthcare for their patients. As a result, such monitoring devices have become an indispensable part of modern medicine.


One technique for monitoring certain physiological characteristics of a patient is commonly referred to as pulse oximetry, and the devices built based upon pulse oximetry techniques are commonly referred to as pulse oximeters. Pulse oximetry may be used to measure various blood flow characteristics, such as the blood-oxygen saturation of hemoglobin in arterial blood, the volume of individual blood pulsations supplying the tissue, and/or the rate of blood pulsations corresponding to each heartbeat of a patient.


The quality of these measurements, however, may be adversely affected by a number of factors such as patient motion, subdermal physiological structures, poor sensor operation or fit, poor signal reception and transmission, and so forth. Such factors may result in a pulse oximetry signal which contains artifacts or noise or is otherwise of low or reduced quality. When processed, such a low or reduced quality signal may result in physiological measurements being reported which may not be as accurate or reliable as desired.


SUMMARY

Certain aspects commensurate in scope with the originally claimed invention are set forth below. It should be understood that these aspects are presented merely to provide the reader with a brief summary of certain forms the invention might take and that these aspects are not intended to limit the scope of the invention. Indeed, the invention may encompass a variety of aspects that may not be set forth below.


There is provided a method for processing a physiological signal, the method including the acts of: performing one or more multi-resolution decompositions on a physiological signal to generate high-passed components and low-passed components; and performing one or more morphological operations on at least one of the high-passed components or the low-passed components generated by the one or more of the respective multi-resolution decompositions.


There is provided one or more machine-readable media, including: a routine configured to perform one or more multi-resolution decompositions on a physiological signal to generate high-passed components and low-passed components; and a routine configured to perform one or more morphological operations on at least one of the high-passed components or the low-passed components generated by the one or more of the respective multi-resolution decompositions.


There is provided a physiological monitoring system, including: a sensor configured to generate a physiological signal; and a monitor configured to display one or more physiological parameters derived from a modified version of the physiological signal, wherein the modified version is generated by performing one or more multi-resolution decompositions on the physiological signal to generate high-passed components and low-passed components, performing one or more morphological operations on at least one of the high-passed components or the low-passed components generated by the one or more of the respective multi-resolution decompositions, and reconstructing the modified version from one or more modified wavelet coefficients generated by the one or more morphological operations.


There is provided a physiological monitoring system, including: a sensor configured to generate a physiological signal; and a monitor configured to perform one or more multi-resolution decompositions on the physiological signal to generate high-passed components and low-passed components, and configured to perform one or more morphological operations on at least one of the high-passed components or the low-passed components generated by the one or more of the respective multi-resolution decompositions.





BRIEF DESCRIPTION OF THE DRAWINGS

Advantages of the invention may become apparent upon reading the following detailed description and upon reference to the drawings in which:



FIG. 1 illustrates a patient monitoring system coupled to a multi-parameter patient monitor and a bi-stable sensor, in accordance with aspects of the present technique;



FIG. 2 is a flowchart of exemplary actions performed in accordance with aspects of the present technique;



FIG. 3A depicts a waveform representing a pulse oximetry signal to be processed in accordance with aspects of the present technique;



FIG. 3B depicts wavelet transformation of the waveform of FIG. 3A, in accordance with aspects of the present technique;



FIG. 3C depicts the wavelet vector of FIG. 3B modified by suitable morphological operations, in accordance with aspects of the present technique; and



FIG. 3D depicts an output waveform reconstructed from the modified wavelet coefficients of FIG. 3C, in accordance with aspects of the present technique.





DETAILED DESCRIPTION OF SPECIFIC EMBODIMENTS

One or more specific embodiments of the present invention will be described below. In an effort to provide a concise description of these embodiments, not all features of an actual implementation are described in the specification. It should be appreciated that in the development of any such actual implementation, as in any engineering or design project, numerous implementation-specific decisions must be made to achieve the developers' specific goals, such as compliance with system-related and business-related constraints, which may vary from one implementation to another. Moreover, it should be appreciated that such a development effort might be complex and time consuming, but would nevertheless be a routine undertaking of design, fabrication, and manufacture for those of ordinary skill having the benefit of this disclosure.


It is desirable to provide an output signal from a pulse oximeter (or other medical monitor) in which the artifacts and/or noise have been removed or reduced. Such a “clean” output signal may then be processed to generate accurate and reliable physiological measurements of interest, such as measurements of blood oxygen level (SpO2), pulse rate, and so forth. In accordance with some aspects of the present technique, an output signal from a medical monitor is pre-processed to remove noise and/or artifacts. The pre-processed signal may then be used to accurately derive the desired physiological measurements of interest.


Turning now to FIG. 1, an exemplary medical monitoring system that may benefit from the present technique is depicted. The exemplary system includes a physiological sensor 10 that may be attached to a patient. The sensor 10 generates an output signal based on a monitored physiological characteristic and transmits the output signal to a patient monitor 12, in accordance with the present technique. In the depicted embodiment, the sensor 10 is connected to the patient monitor 12 via a cable 14 suitable for transmission of the output signal as well as any other electrical and/or optical signals or impulses communicated between the sensor 10 and monitor 12. As will be appreciated by those of ordinary skill in the art, the sensor 10 and/or the cable 14 may include or incorporate one or more integrated circuit devices or electrical devices, such as a memory, processor chip, or resistor, that may facilitate or enhance communication between the sensor 10 and the patient monitor 12. Likewise the cable 14 may be an adaptor cable, with or without an integrated circuit or electrical device, for facilitating communication between the sensor 10 and various types of monitors, including older or newer versions of the patient monitor 12 or other physiological monitors. In other embodiments, the sensor 10 and the patient monitor 12 may communicate via wireless means, such as using radio, infrared, or optical signals. In such embodiments, a transmission device (not shown) may be connected to the sensor 10 to facilitate wireless transmission between the sensor 10 and the patient monitor 12.


In one embodiment, the patient monitor 12 may be a suitable pulse oximeter, such as those available from Nellcor Puritan Bennett Inc. In other embodiments, the patient monitor 12 may be a monitor suitable for measuring other physiological characteristics (such as tissue water fraction, tissue or blood carbon dioxide levels, and so forth) using spectrophotometric or other techniques. Furthermore, the monitor 12 may be a multi-purpose monitor suitable for performing pulse oximetry and/or other physiological and/or biochemical monitoring processes using data acquired via the sensor 10. Furthermore, to provide additional or enhanced functions to those performed by the monitor 12, the patient monitor 12 may be coupled to a multi-parameter patient monitor 16 via a cable 18 connected to a sensor input port and/or via a cable 20 connected to a digital communication port.


As noted above the data provided to the monitor 12 (or, alternatively, to the multi-parameter monitor 16) is generated at the sensor 10. In the example depicted in FIG. 1, the sensor 10 is an exemplary spectrophotometry sensor (such as a pulse oximetry sensor or probe) that includes an emitter 22 and a detector 24 which may be of any suitable type. For example, the emitter 22 may be one or more light emitting diodes adapted to transmit one or more wavelengths of light, such as in the red to infrared range, and the detector 24 may be a photodetector, such as a silicon photodiode package, selected to receive light in the range emitted from the emitter 22. In the depicted embodiment, the sensor 10 is coupled to a cable 14 through which electrical and/or optical signals may be transmitted to and/or from the emitter 22 and detector 24. The sensor 10 may be configured for use with the emitter and detector on the same side of the sensor site (i.e., as a “reflectance type” sensor) or on opposite sides of the sensor site (i.e., as a “transmission type” sensor). During operation, the emitter 22 shines one or more wavelengths of light through the patient's fingertip, or other tissue, and the light received by the detector 24 is processed to determine one or more physiological characteristics of the patient.


For example, for pulse oximetry applications the oxygen saturation of the patient's arterial blood (SaO2) may be determined using two or more wavelengths of light emitted by the emitter 22, most commonly red and near infrared wavelengths. After passage through the patient's tissue, a portion of the light emitted at these wavelengths is detected by the detector 24. The detector generates one or more signals, such an electrical or optical signals, in response to the amount of each wavelength that is detected at a given time. The generated signals may be digital or, where acquired as analog signals, may be digitized in implementations where digital processing and manipulation of the signals is employed. Such digitalization may be performed at the monitor 12 or prior to reaching the monitor 12. The signals, as noted above, may be transmitted via the cable 14 to the monitor 12, where the oxygen saturation or other physiological characteristic is calculated based on the signals. The signals output received by the monitor 12 for processing may be noisy or contain artifacts due to a variety of factors, such as light modulation by subdermal anatomic structures, patient motion during data acquisition, poor sensor operation or fit, poor signal reception and transmission, and so forth. In such instances, the physiological characteristics (such as blood oxygen levels) derived based on such noisy or artifact-containing data signals may in turn be inaccurate or unreliable.


In an embodiment of the present technique, the output signals are pre-processed prior to deriving the one or more physiological characteristics. An example of such an embodiment is set forth in FIG. 2, depicting a pre-processing technique 38 for use in removing noise and artifacts from a physiological signal. In this example, an oximetry data signal 40, i.e., a plethysmographic waveform, such as may be generated by a sensor 10 suitable for pulse oximetry, is pre-processed to remove artifacts and noise prior to extraction of the desired physiological data. While the pre-processing of the data signal 40 may merely be a prelude to further processing for physiological parameters, one of ordinary skill in the art will appreciate that the pre-processed signal may itself be of interest. For example, the pre-processed signal may itself be monitored or used to generate alarms where appropriate.


In accordance with an embodiment of the present technique, the oximetry data signal 40 may, optionally, be filtered (block 42) to smooth out or remove aspects of the signal 40 which are not believed to be representative of the desired physiological data, thereby generating a filtered signal 44. For example, in one implementation the oximetry signal 40 is median filtered at block 40 to remove outlier noise that may be the result of electronic noise or other non-physiological factors. Such filtered signals 44 may then be further processed in accordance with the present technique.


The oximetry signals 40 (or filtered signals 44) may then be processed using a multi-resolution decomposition technique to decompose the signals into time-frequency or time-scale components, such as by discrete wavelet transformation (block 46) via a filter bank or other multiple or iterative decomposition implementation. Such decompositions provide time and frequency information about the decomposed signal which may be subsequently processed. Though wavelet transformation is discussed herein, those of ordinary skill in the art will appreciate that other transformation techniques capable of providing the desired time and frequency information may also be employed and are within the scope of the present technique.


As will be appreciated by those of ordinary skill in the art, each wavelet decomposition yields a low frequency or low-passed signal component 48 in the form of wavelet coefficients, which corresponds to an approximation of the signal undergoing decomposition, and a high frequency or high-passed signal component 50, which corresponds to detail components of the signal undergoing decomposition. In one implementation, each iteration, i.e., resolution level, of the decomposition decomposes the previous approximation, i.e., low-passed component 48, yielding an approximation and detail component representative of the previous approximation. In other words, the low-passed component 48 at the previous resolution level is decomposed to yield the high-passed 50 and low-passed components 48 of the current resolution level. Because the low-passed components 48 are iteratively decomposed in such an implementation, each previous resolution level may be reproduced by reintegrating the low-passed 48 and high-passed components 50 (i.e., the approximation and details) of the current resolution level. Similarly, the initial signal may be reproduced by reintegrating the current resolution level of approximation and details along with previous resolution levels of detail.


Some or all of the high-passed 50 and/or low-passed 48 filtered components generated at some or all of the decomposition resolution levels may be processed using one or more morphological operations (block 56) to generate modified wavelet coefficients 58 which may be subsequently reconstructed to generate an output waveform with reduced noise and/or artifacts. In one embodiment, the morphological operations smooth out the low-passed components 48 (i.e., approximations) and/or the high-passed components 50 (i.e., the details). For example, morphological operations performed on some or all of the filtered components at selected resolution levels may remove noise, facilitate the detection of transient edges, and/or facilitate the identification of a cutoff scale from which the processed signal will be reconstructed. In this manner, analysis at the subsequent resolution level may be facilitated.


For example, in one embodiment, the oximetry signal 40 (or filtered signal 44) undergoes a three-stage wavelet decomposition to generate the respective high-passed components 50 and low-passed components 48. In one implementation, morphological operations are applied to all three resulting scales generated by the first two rounds of wavelet decomposition. In another implementation, only the two high-pass sub-bands are processed with morphological filters after two rounds of wavelet decomposition. In general, the morphological operations performed may be selected based on the frequency of the respective components, i.e., different morphological filtering schemes may be applied to different frequency ranges or scales of the wavelet transformed signal.


Examples of morphological operations that may be performed at block 56 include dilation and erosion operations or other forms of direction, structural, and/or shape-based filtering operations. Typically in such operations, a shape or pattern is presumed to be present in the data and the filter operation is performed accordingly to emphasize or enhance portions of the data where more points are expected (i.e., a dilation) and/or to remove portions of the data where fewer points are expected (i.e., an erosion). As will be appreciated by those of ordinary skill in the art, different effects may be accomplished in the data by varying the number of erosion and/or dilation operations performed or by varying the order in which an erosion and a dilation operation are performed.


For example, in one embodiment, multiple periods or pulses of waveform data (such as 10 samples) may be analyzed prior to determine an average or underlying shape of the waveform, i.e., the expected structural elements. This average or underlying shape may then be used as a template or expected shape for the subsequent morphological operations. In this way, erosions, dilations, or other morphological operations may be performed on the data to compensate for differences between the measured data and the expected structural elements within the data, thereby compensating for artifacts which may cause deviations from the expected structural elements. As will be appreciated by those of ordinary skill in the art, the structural elements may differ at different resolutions, such as having different amplitudes, slope changes and so forth. Likewise, the artifacts being compensated may be multi-dimensional with their own wavelet components at some or all of the resolution levels. Therefore, identification of structural elements and compensation for artifacts via morphological operations may vary depending on the respective resolution level.


The decomposition and morphological filtering operations may continue until a set number of iterations have been performed or until some other threshold has been reached, as determined at block 60. For instance, in one embodiment, the decomposition process is performed until the difference threshold between successive decomposed components, such as low-passed components 48, is below a desired difference threshold. Such a threshold may be empirically determined from a database of coefficients and differences or by other means. While the present example depicts only the low-passed components 48 as being iteratively decomposed, those of ordinary skill in the art will appreciate that, in other implementations, some or all of the high-passed components 50 may also be iteratively decomposed.


The combination of morphological operations performed at block 56 on the respective high-passed 50 and/or low-passed components 48 result in modified wavelet coefficients 58 which, once pre-processing is determined to be complete at block 60, may be reconstructed (block 62) to generate the desired clean waveform 64. This clean waveform 64, in turn, may be processed to determine one or more physiological characteristics of interest, such as respiratory information, blood oxygen saturation, pulse rate, and so forth.


Referring now to FIGS. 3A-3D, example waveforms representative of the technique set forth in FIG. 2 are provided for the purpose of illustration. FIG. 3A depicts an oximetry signal 40, as provide in FIG. 2. The signal 40 of FIG. 3A contains noise and artifacts which are undesirable and which may lead to inaccuracies in subsequent data analyses. FIG. 3B depicts a three-stage wavelet decomposition 70 of the original signal 40. The three-stage decomposition 70 includes a first high-passed component 72. The first low-passed component was further decomposed to yield a second high-passed component 74 and a second low-passed component that was in turn subsequently decomposed to generate a third low-passed component 76 and a third high-passed component 78. The third low-passed component 76 represents the approximation data for the original signal while the first, second, and third high-passed components 72, 74, 78 represent different levels of detail. FIG. 3C depicts the modified wavelet vector 80 generated by performing morphological operations (such as erosion and dilation operations) on all the components of the three-stage decomposition 70. Morphological operations can also be applied to only the selected components at certain levels such as the first and second high passed components 72 and 74. The modified wavelet vector 80 provides the wavelet coefficients 58 that may be reconstructed, such as by an inverse wavelet transform, to generate the output waveform 64 of FIG. 2. In such an embodiment, the inverse wavelet transform preserves the original physiological data while allowing artifact compensation, as opposed to techniques using synthesized waveforms (such as triangular synthetic waveforms) where physiological information may be lost. The output waveform 64 is smoothed out relative to the original signal 40 with much of the noise and artifacts of the original signal removed. The output waveform 64 may be provided to subsequent processes for the determination of physiological characteristics of interest, such as blood oxygen saturation, pulse rate and so forth.


As will be appreciated by those of ordinary skill in the art, the techniques and processes discussed herein may be implemented as one or more automated routines or processes which may be stored and/or executed on suitable components of the monitor 12 or multi-parameter monitor 16. Alternatively, to the extent memory components and/or processing components may be provided on the sensor 10 and/or cable 14, 18, or 20, some or all aspects of the present technique may be stored and/or executed by these respective components. Furthermore, different aspects of the present technique may be stored and/or executed on different portions of a suitable physiological monitoring system where such divisions are desirable.


While the invention may be susceptible to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and have been described in detail herein. However, it should be understood that the invention is not intended to be limited to the particular forms disclosed. Rather, the invention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention as defined by the following appended claims. Indeed, the present techniques may not only be applied to pulse oximetry, but also to other physiological monitor outputs as well.

Claims
  • 1. A method for processing a physiological signal, the method performed on a processing component and comprising the acts of: performing one or more multi-resolution decompositions on a median filtered physiological signal to generate high-passed components and low-passed components; andperforming one or more morphological operations on at least one of the high-passed components or the low-passed components, wherein the morphological operation is performed based on a shape or pattern presumed to be present in the physiological signal.
  • 2. The method of claim 1, wherein the physiological signal is a waveform.
  • 3. The method of claim 1, wherein the one or more multi-resolution decompositions comprise one or more wavelet decompositions.
  • 4. The method of claim 1, wherein the one or more morphological operations comprise at least one of an erosion or a dilation.
  • 5. The method of claim 1, wherein the physiological signal comprises a pulse oximetry signal.
  • 6. The method of claim 1, wherein the one or more multi-resolution decompositions and the one or more morphological operations are performed iteratively.
  • 7. The method of claim 1, comprising iteratively performing one or more multi-resolution decompositions on respectively generated low-passed components.
  • 8. The method of claim 1, wherein the one or more multi-resolution decompositions are implemented as a filter bank.
  • 9. The method of claim 1, comprising reconstructing an output waveform from one or more modified wavelet coefficients generated by the one or more morphological operations.
  • 10. The method of claim 9, wherein reconstructing the output waveform comprises performing an inverse wavelet transform of the one or more modified wavelet coefficients.
  • 11. The method of claim 9 wherein the output waveform comprises a clean pulse oximetry signal.
  • 12. One or more tangible machine-readable media, comprising routines, which when executed by a processor: perform one or more multi-resolution decompositions on a median filtered physiological signal to generate high-passed components and low-passed components; andperform one or more morphological operations on at least one of the high-passed components or the low-passed components, wherein the morphological operation is performed based on a shape or pattern presumed to be present in the physiological signal.
  • 13. The one or more tangible machine-readable media of claim 12, wherein the one or more multi-resolution decompositions comprise one or more wavelet decompositions.
  • 14. The one or more tangible machine-readable media of claim 12, wherein the one or more morphological operations comprise at least one of an erosion or a dilation.
  • 15. The one or more tangible machine-readable media of claim 12, wherein the routine configured to perform the one or more multi-resolution decompositions and the routine for performing one or more morphological operations are implemented iteratively.
  • 16. The one or more tangible machine-readable media of claim 12, comprising a routine configured to iteratively perform one or more multi-resolution decompositions on respectively generated low-passed components.
  • 17. The one or more tangible machine-readable media of claim 12, wherein the one or more multi-resolution decompositions are implemented as a filter bank.
  • 18. The one or more tangible machine-readable media of claim 12, comprising a routine configured to reconstruct an output waveform from one or more modified wavelet coefficients generated by the one or more morphological operations.
  • 19. The one or more tangible machine-readable media of claim 18, wherein the routine configured to reconstruct the output waveform performs an inverse wavelet transform of the one or more modified wavelet coefficients.
  • 20. A physiological monitoring system, comprising: a sensor configured to generate a physiological signal; anda monitor configured to display one or more physiological parameters derived from a modified version of the physiological signal, wherein the modified version is generated by the monitor by median filtering the physiological signal, performing one or more multi-resolution decompositions on the median filtered physiological signal to generate high-passed components and low-passed components, performing one or more morphological operations based on an expected shape or pattern on at least one of the high-passed components or the low-passed components, and reconstructing the modified version from one or more modified wavelet coefficients generated by the one or more morphological operations.
  • 21. The physiological monitoring system of claim 20, wherein the one or more multi-resolution decompositions comprise one or more wavelet decompositions.
  • 22. The physiological monitoring system of claim 20, wherein the one or more morphological operations comprise at least one of an erosion or a dilation.
  • 23. The physiological monitoring system of claim 20, wherein the physiological signal comprises a pulse oximetry signal.
  • 24. The physiological monitoring system of claim 20, wherein the one or more multi-resolution decompositions and the one or more morphological operations are performed iteratively.
  • 25. The physiological monitoring system of claim 20, wherein the one or more multi-resolution decompositions are implemented as a filter bank.
  • 26. A physiological monitoring system, comprising: a sensor configured to generate a physiological signal; anda monitor configured to median filter the physiological signal, to perform one or more multi-resolution decompositions on the median filtered physiological signal to generate high-passed components and low-passed components, and to perform one or more morphological operations based on an expected shape or pattern on at least one of the high-passed components or the low-passed components.
  • 27. The physiological monitoring system of claim 26, wherein the one or more multi-resolution decompositions comprise one or more wavelet decompositions.
  • 28. The physiological monitoring system of claim 26, wherein the one or more morphological operations comprise at least one of an erosion or a dilation.
  • 29. The physiological monitoring system of claim 26, wherein the monitor is configured to perform the one or more multi-resolution decompositions and the one or more morphological operations iteratively.
  • 30. The physiological monitoring system of claim 26, wherein the monitor is configured to iteratively perform one or more multi-resolution decompositions on respectively generated low-passed components.
  • 31. The physiological monitoring system of claim 26, wherein the one or more multi-resolution decompositions are implemented as a filter bank.
  • 32. The physiological monitoring system of claim 26, wherein the monitor is configured to reconstruct an output waveform from one or more modified wavelet coefficients generated by the one or more morphological operations.
  • 33. The physiological monitoring system of claim 32, wherein the monitor is configured apply an inverse wavelet transform to the one or more modified wavelet coefficients to reconstruct the output waveform.
US Referenced Citations (262)
Number Name Date Kind
3638640 Shaw Feb 1972 A
4714341 Hamaguri et al. Dec 1987 A
4805623 Jöbsis Feb 1989 A
4807631 Hersh et al. Feb 1989 A
4911167 Corenman et al. Mar 1990 A
4913150 Cheung et al. Apr 1990 A
4936679 Mersch Jun 1990 A
4938218 Goodman et al. Jul 1990 A
4971062 Hasebe et al. Nov 1990 A
4972331 Chance Nov 1990 A
4974591 Awazu et al. Dec 1990 A
5028787 Rosenthal et al. Jul 1991 A
5065749 Hasebe et al. Nov 1991 A
5084327 Stengel Jan 1992 A
5119815 Chance Jun 1992 A
5122974 Chance Jun 1992 A
5167230 Chance Dec 1992 A
5190038 Polson et al. Mar 1993 A
5246003 DeLonzor Sep 1993 A
5247931 Norwood Sep 1993 A
5263244 Centa et al. Nov 1993 A
5275159 Griebel Jan 1994 A
5279295 Martens et al. Jan 1994 A
5297548 Pologe Mar 1994 A
5355880 Thomas et al. Oct 1994 A
5372136 Steuer et al. Dec 1994 A
5385143 Aoyagi Jan 1995 A
5390670 Centa et al. Feb 1995 A
5413099 Schmidt et al. May 1995 A
5469845 DeLonzor et al. Nov 1995 A
5482036 Diab et al. Jan 1996 A
5483646 Uchikoga Jan 1996 A
5521851 Wei et al. May 1996 A
5553614 Chance Sep 1996 A
5564417 Chance Oct 1996 A
5575285 Takanashi et al. Nov 1996 A
5588427 Tien Dec 1996 A
5611337 Bukta Mar 1997 A
5630413 Thomas et al. May 1997 A
5645059 Fein et al. Jul 1997 A
5645060 Yorkey Jul 1997 A
5680857 Pelikan et al. Oct 1997 A
5692503 Keunstner Dec 1997 A
5730124 Yamauchi Mar 1998 A
5758644 Diab et al. Jun 1998 A
5779631 Chance Jul 1998 A
5782757 Diab et al. Jul 1998 A
5786592 Hök Jul 1998 A
5830136 DeLonzor et al. Nov 1998 A
5830139 Abreu Nov 1998 A
5831598 Kauffert et al. Nov 1998 A
5842981 Larsen et al. Dec 1998 A
5871442 Madarasz et al. Feb 1999 A
5873821 Chance et al. Feb 1999 A
5920263 Huttenhoff et al. Jul 1999 A
5921937 Davis et al. Jul 1999 A
5995855 Kiani et al. Nov 1999 A
5995856 Mannheimer et al. Nov 1999 A
5995859 Takahashi Nov 1999 A
6011985 Athan et al. Jan 2000 A
6011986 Diab et al. Jan 2000 A
6064898 Aldrich May 2000 A
6081742 Amano et al. Jun 2000 A
6088607 Diab et al. Jul 2000 A
6094592 Yorkey et al. Jul 2000 A
6120460 Abreu Sep 2000 A
6134460 Chance Oct 2000 A
6150951 Olejniczak Nov 2000 A
6154667 Miura et al. Nov 2000 A
6163715 Larsen et al. Dec 2000 A
6181958 Steuer et al. Jan 2001 B1
6181959 Schöllermann et al. Jan 2001 B1
6222189 Misner et al. Apr 2001 B1
6230035 Aoyagi et al. May 2001 B1
6266546 Steuer et al. Jul 2001 B1
6285895 Ristolainen et al. Sep 2001 B1
6312393 Abreu Nov 2001 B1
6352502 Chaiken et al. Mar 2002 B1
6353750 Kimura et al. Mar 2002 B1
6361501 Amano et al. Mar 2002 B1
6393311 Edgar et al. May 2002 B1
6397091 Diab et al. May 2002 B2
6415236 Kobayashi et al. Jul 2002 B2
6419671 Lemberg Jul 2002 B1
6438399 Kurth Aug 2002 B1
6449501 Reuss Sep 2002 B1
6461305 Schnall Oct 2002 B1
6466809 Riley Oct 2002 B1
6487439 Skladnev et al. Nov 2002 B1
6496711 Athan et al. Dec 2002 B1
6501974 Huiku Dec 2002 B2
6501975 Diab et al. Dec 2002 B2
6519486 Edgar et al. Feb 2003 B1
6526301 Larsen et al. Feb 2003 B2
6544193 Abreu Apr 2003 B2
6546267 Sugiura et al. Apr 2003 B1
6549795 Chance Apr 2003 B1
6580086 Schulz et al. Jun 2003 B1
6584336 Ali et al. Jun 2003 B1
6587704 Fine et al. Jul 2003 B1
6591122 Schmitt Jul 2003 B2
6594513 Jobsis et al. Jul 2003 B1
6606509 Schmitt Aug 2003 B2
6606511 Ali et al. Aug 2003 B1
6615064 Aldrich Sep 2003 B1
6618042 Powell Sep 2003 B1
6622095 Kobayashi et al. Sep 2003 B2
6650918 Terry Nov 2003 B2
6654621 Palatnik et al. Nov 2003 B2
6654622 Eberhard et al. Nov 2003 B1
6654623 Kastle Nov 2003 B1
6654624 Diab et al. Nov 2003 B2
6658276 Kianl et al. Dec 2003 B2
6658277 Wasserman Dec 2003 B2
6662030 Khalil et al. Dec 2003 B2
6668183 Hicks et al. Dec 2003 B2
6671526 Aoyagi et al. Dec 2003 B1
6671528 Steuer et al. Dec 2003 B2
6678543 Diab et al. Jan 2004 B2
6684090 Ali et al. Jan 2004 B2
6690958 Walker et al. Feb 2004 B1
6697658 Al-Ali Feb 2004 B2
6708048 Chance Mar 2004 B1
6711424 Fine et al. Mar 2004 B1
6711425 Reuss Mar 2004 B1
6714245 Ono Mar 2004 B1
6731274 Powell May 2004 B2
6778923 Norris et al. Aug 2004 B2
6785568 Chance Aug 2004 B2
6793654 Lemberg Sep 2004 B2
6801797 Mannheimer et al. Oct 2004 B2
6801798 Geddes et al. Oct 2004 B2
6801799 Mendelson Oct 2004 B2
6810277 Edgar et al. Oct 2004 B2
6829496 Nagai et al. Dec 2004 B2
6850053 Daalmans et al. Feb 2005 B2
6863652 Huang et al. Mar 2005 B2
6873865 Steuer et al. Mar 2005 B2
6889153 Dietiker May 2005 B2
6898451 Wuori May 2005 B2
6931269 Terry Aug 2005 B2
6939307 Dunlop Sep 2005 B1
6947780 Scharf Sep 2005 B2
6949081 Chance Sep 2005 B1
6961598 Diab Nov 2005 B2
6983178 Fine et al. Jan 2006 B2
6987994 Mortz Jan 2006 B1
6993371 Kiani et al. Jan 2006 B2
6996427 Ali et al. Feb 2006 B2
7020507 Scharf et al. Mar 2006 B2
7024235 Melker et al. Apr 2006 B2
7027849 Al-Ali Apr 2006 B2
7030749 Al-Ali Apr 2006 B2
7035679 Addison et al. Apr 2006 B2
7035697 Brown Apr 2006 B1
7047056 Hannula et al. May 2006 B2
7072702 Edgar et al. Jul 2006 B2
7079880 Stetson Jul 2006 B2
7127278 Melker et al. Oct 2006 B2
7162306 Caby et al. Jan 2007 B2
7209775 Bae et al. Apr 2007 B2
7215984 Diab et al. May 2007 B2
7215986 Diab et al. May 2007 B2
7225013 Geva et al. May 2007 B2
7236811 Schmitt Jun 2007 B2
7254433 Diab et al. Aug 2007 B2
7263395 Chan et al. Aug 2007 B2
7272426 Schmid Sep 2007 B2
7289835 Mansfield et al. Oct 2007 B2
7328053 Diab et al. Feb 2008 B1
7336982 Yoo Feb 2008 B2
7343187 Stetson Mar 2008 B2
7373193 Al-Ali et al. May 2008 B2
7376453 Diab et al. May 2008 B1
7383070 Diab et al. Jun 2008 B2
7398115 Lynn Jul 2008 B2
7515949 Norris Apr 2009 B2
20010005773 Larsen et al. Jun 2001 A1
20010020122 Steuer et al. Sep 2001 A1
20010039376 Steuer et al. Nov 2001 A1
20010044700 Kobayashi et al. Nov 2001 A1
20020026106 Khalil et al. Feb 2002 A1
20020035318 Mannheimer et al. Mar 2002 A1
20020038079 Steuer et al. Mar 2002 A1
20020042558 Mendelson Apr 2002 A1
20020049389 Abreu Apr 2002 A1
20020062071 Diab et al. May 2002 A1
20020111748 Kobayashi et al. Aug 2002 A1
20020133068 Huiku Sep 2002 A1
20020156354 Larson Oct 2002 A1
20020161287 Schmitt Oct 2002 A1
20020161290 Chance Oct 2002 A1
20020165439 Schmitt Nov 2002 A1
20020198443 Ting Dec 2002 A1
20030023140 Chance Jan 2003 A1
20030055324 Wasserman Mar 2003 A1
20030060693 Monfre et al. Mar 2003 A1
20030139687 Abreu Jul 2003 A1
20030144584 Mendelson Jul 2003 A1
20030220548 Schmitt Nov 2003 A1
20030220576 Diab Nov 2003 A1
20030225337 Scharf et al. Dec 2003 A1
20040010188 Wasserman Jan 2004 A1
20040054270 Pewzner et al. Mar 2004 A1
20040054281 Adam et al. Mar 2004 A1
20040087846 Wasserman May 2004 A1
20040107065 Al-Ali Jun 2004 A1
20040116788 Chernoguz et al. Jun 2004 A1
20040127779 Steuer et al. Jul 2004 A1
20040171920 Mannheimer et al. Sep 2004 A1
20040176670 Takamura et al. Sep 2004 A1
20040176671 Fine et al. Sep 2004 A1
20040193065 Houben Sep 2004 A1
20040230106 Schmitt et al. Nov 2004 A1
20050033129 Edgar et al. Feb 2005 A1
20050049470 Terry Mar 2005 A1
20050070774 Addison et al. Mar 2005 A1
20050080323 Kato Apr 2005 A1
20050101850 Parker May 2005 A1
20050113651 Wood et al. May 2005 A1
20050113656 Chance May 2005 A1
20050131286 Parker et al. Jun 2005 A1
20050168722 Forstner et al. Aug 2005 A1
20050177034 Beaumont Aug 2005 A1
20050192488 Bryenton et al. Sep 2005 A1
20050192493 Wuori Sep 2005 A1
20050203357 Debreczeny et al. Sep 2005 A1
20050209517 Diab et al. Sep 2005 A1
20050228248 Dietiker Oct 2005 A1
20050267346 Faber et al. Dec 2005 A1
20050283059 Iyer et al. Dec 2005 A1
20060009688 Lamego et al. Jan 2006 A1
20060015021 Cheng Jan 2006 A1
20060020181 Schmitt Jan 2006 A1
20060030763 Mannheimer et al. Feb 2006 A1
20060052680 Diab Mar 2006 A1
20060058683 Chance Mar 2006 A1
20060064024 Schnall Mar 2006 A1
20060149144 Lynn Jul 2006 A1
20060155206 Lynn Jul 2006 A1
20060189880 Lynn et al. Aug 2006 A1
20060195028 Hannula et al. Aug 2006 A1
20060200016 Diab et al. Sep 2006 A1
20060209631 Melese et al. Sep 2006 A1
20060211930 Scharf et al. Sep 2006 A1
20060217609 Diab et al. Sep 2006 A1
20060224058 Mannheimer Oct 2006 A1
20060247501 Ali Nov 2006 A1
20060258921 Addison et al. Nov 2006 A1
20060258927 Edgar et al. Nov 2006 A1
20060293574 Norris Dec 2006 A1
20070004977 Norris Jan 2007 A1
20070213621 Reisfeld et al. Sep 2007 A1
20070213622 Reisfeld Sep 2007 A1
20070225581 Diab et al. Sep 2007 A1
20070249918 Diab et al. Oct 2007 A1
20070291832 Diab et al. Dec 2007 A1
20080004514 Diab et al. Jan 2008 A1
20080033266 Diab et al. Feb 2008 A1
20080036752 Diab et al. Feb 2008 A1
20080045823 Diab et al. Feb 2008 A1
20080066753 Martin et al. Mar 2008 A1
Foreign Referenced Citations (38)
Number Date Country
19640807 Sep 1997 DE
0630203 Dec 1994 EP
1491135 Dec 2004 EP
3170866 Jul 1991 JP
3238813 Oct 1991 JP
4191642 Jul 1992 JP
4332536 Nov 1992 JP
7124138 May 1995 JP
7136150 May 1995 JP
10216115 Aug 1998 JP
2003194714 Jul 2003 JP
2003210438 Jul 2003 JP
2003275192 Sep 2003 JP
2003339678 Dec 2003 JP
2004008572 Jan 2004 JP
2004113353 Apr 2004 JP
2004135854 May 2004 JP
2004194908 Jul 2004 JP
2004202190 Jul 2004 JP
2004248819 Sep 2004 JP
2004290545 Oct 2004 JP
WO9101678 Feb 1991 WO
WO9221281 Dec 1992 WO
WO9309711 May 1993 WO
WO9403102 Feb 1994 WO
WO9512349 May 1995 WO
WO9749330 Dec 1997 WO
WO9842249 Oct 1998 WO
WO9842251 Oct 1998 WO
WO9843071 Oct 1998 WO
WO9932030 Jul 1999 WO
WO0021438 Apr 2000 WO
WO0125802 Apr 2001 WO
WO03000125 Jan 2003 WO
WO 2004075746 Sep 2004 WO
WO2004075746 Sep 2004 WO
WO2005009221 Feb 2005 WO
WO2006097437 Sep 2006 WO
Related Publications (1)
Number Date Country
20070073120 A1 Mar 2007 US